Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Washington University in St. Louis

Headquarters: St. Louis, MO, United States of America
Year Founded: 1853
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Nov 6, 2024
Distillery Therapeutics

NR4A1 activation for UTIs

BioCentury | Oct 31, 2024
Discovery & Translation

Science Spotlight: Macrophage-fibroblast cross-talk in heart failure

BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
BioCentury | Aug 1, 2024
Distillery Therapeutics

LILRB4 inhibitory mAb for Alzheimer’s diseae

BioCentury | Feb 21, 2024
Discovery & Translation

LDL receptor decoys: an emerging strategy for alphaviruses

Engineered proteins mimicking host low-density lipoprotein receptors could block cellular entry by a wide range of alphaviruses 
BioCentury | Jan 16, 2024
Regulation

Jan. 16 Quick Takes: Casgevy gains quick label expansion in β-thalassemia

Plus: Deerfield adds Washington University in St. Louis to arsenal of academic center collaborations and updates from Allakos, GSK  
BioCentury | Aug 17, 2023
Discovery & Translation

Improved transgene insertion; plus Synlogic’s autoimmune probiotic and more

BioCentury’s roundup of translational innovations
BioCentury | Mar 8, 2023
Distillery Therapeutics

Chimeric receptor to clear apoptotic cells in inflammation

BioCentury | Feb 2, 2023
Emerging Company Profile

PrecisionLife: learning from genetic interactions by cutting noise

U.K. company untangling genomic interactions to find targets in complex diseases
Items per page:
1 - 10 of 166